Weekly renewables M&A round-up (May 23-27)
May 27, 2022 17:26 CESTSunways gets 295-kW BIPV equipment order in US from Novartis
(SeeNews) - Oct 17, 2012 - German solar firm Sunways AG (ETR:SWW) said today it had received an order to supply 295 kW of building-integrated photovoltaic (BIPV) cells to the US head office of Swiss drug maker Novartis (VTX:NOVN).
The deal includes the installation of 161,000 monocrystalline, semitransparent design solar cells on the roof of a building in East Hanover, New Jersey.
The German company did not disclose any financial details of the deal.
The worldwide market for BIPV walling is expected to surpass USD 1.5 billion (EUR 1.1bn) by 2016, market researcher NanoMarkets said in a study published at the beginning of September 2012.
(USD 1.0 = EUR 0.763)
More stories to explore
Duke Energy equips Hawaii university with solar and storage
May 27, 2022 17:17 CEST
US stays atop EY renewables attractiveness index, Spain heads PPA chart
May 27, 2022 16:32 CEST
Savannah Energy to develop up to 500 MW of renewables in Chad
May 27, 2022 16:08 CEST
Celsia building 260 MW of solar farms in Colombia
May 27, 2022 15:51 CEST
Agrana, RWA equip Austrian fruit juice concentrate plant with solar modules
May 27, 2022 15:36 CESTShare this story
Tags
About the author